AEZS

Aeterna Zentaris’ Marketing Authorization Application for Macrilen™ (macimorelin) for Evaluation of Adult Growth Hormone Deficiency Accepted by European Medicines Agency

Aeterna Zentaris Inc. (AEZS-NASDAQ) announced the Marketing Authorization Application (MAA) for the use of ...

Karen Goldfarb

November 28, 2017 at 10:14 AM

NDA for Aeterna Zentaris' (AEZS) Macrilen™ Granted December 30, 2017 PDUFA Date

Aeterna Zentaris Inc. (AEZS-NASDAQ) announced that it has been notified by the U.S. Food and Drug ...

Karen Goldfarb

July 19, 2017 at 11:23 AM

May 2017 Update Released on Aeterna Zentaris (AEZS)

Crystal Research Associates has released an 11-page Quarterly Update on specialty biopharmaceutical company, ...

Karen Goldfarb

May 15, 2017 at 2:59 PM

April 2017 Update Released on Aeterna Zentaris (AEZS)

Crystal Research Associates has released an 11-page Quarterly Update on specialty biopharmaceutical company, ...

Karen Goldfarb

April 5, 2017 at 1:33 PM

Aeterna-Zentaris-AEZS-Quarterly-Update-02-27-2017_p1.bmp

February 2017 Update Released on Aeterna Zentaris (AEZS)

Crystal Research Associates has released a 10-page Quarterly Update on specialty biopharmaceutical company, ...

Karen Goldfarb

February 27, 2017 at 2:56 PM

September 2016 Update Released on Aeterna Zentaris (AEZS)

Crystal Research Associates has released a 16-page Quarterly Update on specialty biopharmaceutical company, ...

Laura Swartz

September 26, 2016 at 9:13 PM

First Quarter 2016 Update on Aeterna Zentaris

Specialty biopharmaceutical company Aeterna Zentaris Inc. (AEZS-NASDAQ; AEZ-TSX) held a conference call and ...

Laura Swartz

May 10, 2016 at 11:43 AM

NEW RESEARCH: Quarterly Update Released on Aeterna Zentaris (AEZS)

Crystal Research Associates has released a 16-page Quarterly Update on specialty biopharmaceutical company, ...

Laura Swartz

April 7, 2016 at 1:55 PM

Positive Phase 2 Data in Prostate Cancer from Biopharma Company Aeterna Zentaris

Aeterna Zentaris Inc. (AEZS) (TSX: AEZ) today announced that its lead oncology compound, zoptarelin ...

Laura Swartz

September 28, 2015 at 12:59 PM

NEW RESEARCH: 12-page Quarterly Update on Aeterna Zentaris (AEZS-NASDAQ)

We published a 12-page Quarterly Update on specialty biopharmaceutical company Aeterna Zentaris, Inc. this ...

Laura Swartz

July 27, 2015 at 11:28 AM

New Slide Deck Available on Specialty Biopharma Company, Aeterna Zentaris Inc.

Crystal Research Associates has released a slide presentation on Aeterna Zentaris Inc. (AEZS-NASDAQ; AEZ-TSX) ...

Laura Swartz

June 11, 2015 at 9:25 AM

Aeterna Zentaris Finalizes Key Promotional Agreement with Merck’s EMD Serono, Inc.

Specialty biopharmaceutical company Aeterna Zentaris Inc. (AEZS-NASDAQ; AEZ-TSX) announced this morning that ...

Laura Swartz

May 7, 2015 at 1:14 PM

NEW RESEARCH: 52-page Report Available on Aeterna Zentaris Inc. (AEZS-NASDAQ)

Crystal Research Associates has issued a comprehensive, 52-page Executive Informational Overview (EIO) on ...

Laura Swartz

April 21, 2015 at 4:11 PM